Veradigm Bundle
Who Owns Veradigm?
Understanding a company's ownership is key to grasping its direction and accountability. Veradigm's delisting from Nasdaq in February 2024 highlights this, stemming from a failure to file financial reports.
Veradigm, a healthcare technology firm, offers electronic health record software, practice management tools, and data analytics. Its network connects over 300,000 U.S. healthcare providers and serves more than 170 million patients.
Tracing Veradigm's ownership reveals its journey from Medic Computer Systems to Allscripts Healthcare Solutions, and its current status. This includes identifying key investors and understanding the role of public shareholders.
Who Founded Veradigm?
Veradigm's origins trace back to 1982 when it was established as Medic Computer Systems. It later rebranded to Allscripts Healthcare Solutions, Inc. in 1986. The company's initial mission was to modernize the healthcare industry by providing practice management and electronic health record (EHR) technology to healthcare providers.
Founding Year
The company was founded in 1982, initially as Medic Computer Systems.
Early Focus
The early focus was on practice management and electronic health record (EHR) technology for healthcare providers.
Rebranding
In 1986, the company underwent a rebranding and became known as Allscripts Healthcare Solutions, Inc.
Founders' Vision
The founding team's vision was to streamline healthcare processes and improve patient care through technological advancements.
Initial Capital
Early angel investors and backers provided the crucial initial capital for the company's foundational growth.
Ownership Structure Genesis
The early ownership structure was instrumental in shaping the company's subsequent evolution and direction.
While specific details regarding the full names of all founders, their backgrounds, and precise equity splits at inception are not extensively documented in public records, the company's early trajectory was clearly aimed at developing solutions to enhance healthcare operations and patient outcomes. The foundational ownership structure would have been critical in guiding the company's initial growth and technological ambitions within the healthcare sector. For a deeper understanding of its early days, one can refer to the Brief History of Veradigm.
Veradigm SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Veradigm’s Ownership Changed Over Time?
Veradigm's ownership journey has been marked by significant transformations, notably its evolution from a subsidiary of Allscripts to a publicly traded entity with a diverse shareholder base. Key milestones include the 2008 merger with Misys Healthcare Systems and the 2010 acquisition of Eclipsys for $1.3 billion, which broadened its market reach and data capabilities. The company officially rebranded as Veradigm Inc. in January 2023, signaling a strategic pivot towards healthcare analytics and technology solutions.
| Shareholder | Ownership Percentage | Approximate Value (USD) |
|---|---|---|
| Stonehill Capital Management LLC | 12.45% | $99 million |
| Vanguard Explorer Value Fund Investor Shares (VEVFX) | ||
| HARTFORD SMALL CAP VALUE FUND Class A (HSMAX) | ||
| Tekla Healthcare Opportunities Fund | ||
| BlackRock Credit Strategies Fund | ||
| MAINSTAY VP FUNDS TRUST - MainStay VP MacKay Small Cap Core Portfolio Initial Class |
Following its delisting from Nasdaq in February 2024 due to issues with timely financial reporting, Veradigm (OTCPK: MDRX) now trades on the over-the-counter market. Despite this, institutional investors remain substantial stakeholders. Stonehill Capital Management LLC stands out as the largest shareholder, controlling 12.45% of the company's equity, estimated at around $99 million. Other significant institutional investors include Vanguard Explorer Value Fund Investor Shares (VEVFX), HARTFORD SMALL CAP VALUE FUND Class A (HSMAX), Tekla Healthcare Opportunities Fund, BlackRock Credit Strategies Fund, and MAINSTAY VP FUNDS TRUST - MainStay VP MacKay Small Cap Core Portfolio Initial Class. In a move to better align employee incentives with shareholder interests, Veradigm expanded its stock incentive plan in May 2025, authorizing an additional 6 million shares for grants, bringing the total to 11 million shares. Insider holdings saw a slight increase from 0.65% to 0.67% as of March 2025.
Understanding Veradigm's Ownership Landscape
Veradigm's corporate ownership structure is primarily characterized by a significant presence of institutional investors. Understanding who owns Veradigm is crucial for assessing its strategic direction and stability.
- Stonehill Capital Management LLC is the largest shareholder.
- Institutional investors collectively hold a substantial portion of Veradigm stock.
- Insider ownership remains a small but notable percentage.
- The company has adjusted its stock incentive plans to foster employee alignment.
- Veradigm's ownership history reflects its transition from a larger entity.
Veradigm PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Veradigm’s Board?
The board of directors at Veradigm is instrumental in guiding the company's strategic direction. As of March 19, 2025, significant board changes occurred following an agreement with Kent Lake PR LLC, an investor holding approximately 4.2% of the company's shares. These changes include the appointment of new independent directors and transitions in key committee leadership, reflecting active shareholder influence on corporate governance.
| Director Name | Role | Committee Affiliation |
|---|---|---|
| Jonathan Sacks | Independent Director | |
| Bruce Felt | Independent Director | Chair of the Audit Committee |
| Louis Silverman | Chairman | |
| Vinit Asar | Chair of the Nominating and Governance Committee | |
| Carol Zierhoffer | Lead Independent Director | |
| David Stevens | Director | |
| Kim Franks | Director | |
| Susan Rodriguez | Director | |
| Jeanne Armstrong | Director | |
| Geoff Caplea | Director | |
| Laura Kohlhaagen | Director | |
| Debbie McKay | Director |
The voting power within Veradigm is structured to allow for significant influence by certain shareholders. While common stock typically adheres to a one-share-one-vote principle, the presence of Series A Preferred Stock, as confirmed in February 2024, grants its holders 1,000 votes per share. This structure can lead to disproportionate control over stockholder decisions, as seen in recent events where activist investors have driven changes in board composition and leadership, impacting the Competitors Landscape of Veradigm.
Understanding Veradigm's Shareholder Influence
Shareholder activism is a key factor in Veradigm's recent governance shifts. The agreement with Kent Lake PR LLC highlights how even a minority stake can prompt significant board changes.
- Kent Lake PR LLC holds approximately 4.2% of Veradigm shares.
- Stonehill Capital Management LLC is Veradigm's largest shareholder.
- Series A Preferred Stock holders possess 1,000 votes per share.
- Board appointments reflect responses to investor demands.
Veradigm Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Veradigm’s Ownership Landscape?
In recent years, Veradigm's ownership landscape has seen significant shifts, including a notable corporate rebranding and challenges with its stock market listing. These events have reshaped its investor profile and strategic direction.
| Event | Date | Impact |
|---|---|---|
| Corporate Name Change (Allscripts to Veradigm) | January 2023 | Strategic pivot towards healthcare analytics and technology |
| Nasdaq Delisting | February 2024 | Stock moved to over-the-counter market due to non-compliance with listing rules |
| Exploration of Strategic Alternatives | May 2024 - January 2025 | No sale proposals received; focus shifted to operational review |
| Acquisition of Koha Health | January 2024 | Expansion of business operations |
| Acquisition of ScienceIO | March 2024 | Further investment in healthcare data capabilities |
The company's ownership structure remains dominated by institutional investors, with Stonehill Capital Management LLC holding the largest stake. Veradigm's strategic moves, including acquisitions and efforts to regain compliance with stock exchange rules, indicate a focus on stabilizing operations and enhancing shareholder value. The expansion of its stock incentive plan in May 2025 aims to align employee interests with those of stockholders, a common practice in the competitive healthcare technology sector. This period of transition also includes a search for a permanent CEO following the departure of the interim CEO in July 2025, underscoring the ongoing efforts to solidify leadership and operational direction.
Largest Shareholder
Stonehill Capital Management LLC is identified as the largest shareholder, indicating significant institutional backing.
Stock Market Status
Veradigm's common stock was delisted from the Nasdaq in February 2024 and is now quoted on an over-the-counter market.
Strategic Alternatives Review
The company explored strategic alternatives, including a potential sale, but concluded this process in January 2025 without a definitive agreement.
Future Outlook
Veradigm aims to become current in its SEC filings during 2026 and subsequently seek to relist its common stock, signaling a path toward renewed market engagement.
Veradigm Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Veradigm Company?
- What is Competitive Landscape of Veradigm Company?
- What is Growth Strategy and Future Prospects of Veradigm Company?
- How Does Veradigm Company Work?
- What is Sales and Marketing Strategy of Veradigm Company?
- What are Mission Vision & Core Values of Veradigm Company?
- What is Customer Demographics and Target Market of Veradigm Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.